This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2024 Sep;23(9):651.

doi: 10.1038/d41573-024-00121-4.

TCR-boosted T cell therapy yields proof-of-principle clinical data in solid cancer

PMID: 39075314
DOI: 10.1038/d41573-024-00121-4

Comment

TCR-boosted T cell therapy yields proof-of-principle clinical data in solid cancer

Asher Mullard. Nat Rev Drug Discov. 2024 Sep.

. 2024 Sep;23(9):651.

doi: 10.1038/d41573-024-00121-4.

Author

PMID: 39075314
DOI: 10.1038/d41573-024-00121-4

No abstract available

PubMed Disclaimer

Comment on

Adoptive transfer of personalized neoantigen-reactive TCR-transduced T cells in metastatic colorectal cancer: phase 2 trial interim results.
Parkhurst M, Goff SL, Lowery FJ, Beyer RK, Halas H, Robbins PF, Prickett TD, Gartner JJ, Sindiri S, Krishna S, Zacharakis N, Ngo L, Ray S, Bera A, Shepherd R, Levin N, Kim SP, Copeland A, Nah S, Levi S, Parikh N, Kwong MLM, Klemen ND, Yang JC, Rosenberg SA. Parkhurst M, et al. Nat Med. 2024 Sep;30(9):2586-2595. doi: 10.1038/s41591-024-03109-0. Epub 2024 Jul 11. Nat Med. 2024. PMID: 38992129 Clinical Trial.

Similar articles

Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers.
Chen L, Qiao D, Wang J, Tian G, Wang M. Chen L, et al. Immunol Lett. 2019 Dec;216:51-62. doi: 10.1016/j.imlet.2019.10.002. Epub 2019 Oct 6. Immunol Lett. 2019. PMID: 31597088 Review.
Constructing co-stimulation to boost TCR therapy.
Höbart J, Ruland J. Höbart J, et al. Nat Cancer. 2024 May;5(5):697-698. doi: 10.1038/s43018-024-00746-9. Nat Cancer. 2024. PMID: 38816622 No abstract available.
Regional Infusion of Chimeric Antigen Receptor T Cells to Overcome Barriers for Solid Tumor Immunotherapy.
Hardaway JC, Prince E, Arepally A, Katz SC. Hardaway JC, et al. J Vasc Interv Radiol. 2018 Jul;29(7):1017-1021.e1. doi: 10.1016/j.jvir.2018.03.001. J Vasc Interv Radiol. 2018. PMID: 29935783 No abstract available.
Redirected T cells in cancer therapy.
Sangiolo D. Sangiolo D. Expert Opin Biol Ther. 2015;15(12):1667-70. doi: 10.1517/14712598.2015.1096340. Epub 2015 Oct 29. Expert Opin Biol Ther. 2015. PMID: 26515608
Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors.
Harris DT, Kranz DM. Harris DT, et al. Trends Pharmacol Sci. 2016 Mar;37(3):220-230. doi: 10.1016/j.tips.2015.11.004. Epub 2015 Dec 17. Trends Pharmacol Sci. 2016. PMID: 26705086 Free PMC article. Review.

See all similar articles

Cited by

Adoptive immune cell therapy for colorectal cancer.
Liu C, Liu N, Zhang T, Tu Y. Liu C, et al. Front Immunol. 2025 Apr 1;16:1557906. doi: 10.3389/fimmu.2025.1557906. eCollection 2025. Front Immunol. 2025. PMID: 40236691 Free PMC article. Review.
Immune repertoire sequencing reveals differences in treatment response to camrelizumab plus platinum-based chemotherapy in advanced ESCC.
Zhang X, Zhao W, Du Y, Su F, Zhang Y, Wang H, Li Y, Liu M, Gao Y, Cai L, Feng T, Wang M, Yao C, Xu N, Wang Y, Song G, Hu W, Zhao J. Zhang X, et al. Front Immunol. 2025 Feb 26;16:1526443. doi: 10.3389/fimmu.2025.1526443. eCollection 2025. Front Immunol. 2025. PMID: 40079001 Free PMC article. Clinical Trial.
Clinical advances and challenges associated with TCR-T cell therapy for cancer treatment.
Li J, Zhang Y, Fu T, Xing G, Cai H, Li K, Xu Y, Tong Y. Li J, et al. Front Immunol. 2024 Oct 8;15:1487782. doi: 10.3389/fimmu.2024.1487782. eCollection 2024. Front Immunol. 2024. PMID: 39439803 Free PMC article. Review.
GNG7 as a tumor-suppressor gene in lung adenocarcinoma: implications for prognosis and immune-based therapies.
Luo K, Liu M, Peng Z, Zhao H, Li G, Cai Y, Lei Y, Zhang H, Zhao Y. Luo K, et al. Front Oncol. 2025 May 27;15:1588646. doi: 10.3389/fonc.2025.1588646. eCollection 2025. Front Oncol. 2025. PMID: 40496619 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
Medical
- MedlinePlus Health Information